What's on this Page
Ciprofloxacin Fluocinolone Brand Name– OTOVEL
What is Ciprofloxacin Fluocinolone
Ciprofloxacin fluocinolone otic solution is indicated for the treatment of acute otitis media due to susceptible organisms in pediatric patients aged 6 months and older with tympanostomy tubes.
Ciprofloxacin is a fluoroquinolone antibiotic with in vitro activity against a wide range of gram-positive and gram-negative microorganisms; topical use in the ear is not associated with ototoxicity.
Fluocinolone is an anti-inflammatory corticosteroid and is included to aid in the resolution of the inflammatory response associated with the bacterial infection.
Ciprofloxacin fluocinolone otic solution was FDA-approved in April 2016
Indications
- Haemophilus influenzae (beta-lactamase negative)
- Haemophilus influenzae (beta-lactamase positive)
- Moraxella catarrhalis
- otitis media
- Pseudomonas aeruginosa
- Staphylococcus aureus (MSSA)
- Streptococcus pneumoniae
Side Effects
- anaphylactoid reactions
- angioedema
- antimicrobial resistance
- candidiasis
- dizziness
- dysgeusia
- dyspnea
- edema
- flushing
- headache
- infection
- laryngeal edema
- otalgia
- paresthesias
- pruritus
- tinnitus
- urticaria
Monitoring Parameters
- laboratory monitoring not necessary
Contraindications
- angioedema
- breast-feeding
- corticosteroid hypersensitivity
- ear discharge
- edema
- fungal infection
- herpes infection
- ophthalmic administration
- parenteral administration
- pregnancy
- quinolone hypersensitivity
- urticaria
- varicella
- viral infection
Interactions
There are no drug interactions associated with Ciprofloxacin Fluocinolone products.
